EGFR and hepatocellular carcinoma: We have previously reported that GALNT1 and GALNT2 are the two major polypeptide GalNAc-transferases in liver and HCC tissues; and overexpression of GALNT2 suppresses EGF-induced EGFR activation and enhances EGFR degradation [12].